Published on:March 2016
    Journal of Pharmacy Practice and Community Medicine, 2016; 2(3):94-95
    Case Report | doi:10.5530/jppcm.2016.3.6


    A Case Report on Nevirapine Induced Autoimmune Hemolytic Anemia


    Authors and affiliation (s):

    Meghana Devulapalli1*, Narasimha Kumar G.V2

    1Department of Pharmacy Practice, Sri Padmavathi School of Pharmacy, Tiruchanoor, Tirupathi, AP, INDIA.

    2Department of Pharmacology, Sri Padmavathi School of Pharmacy, Tiruchanoor, Tirupathi, AP, INDIA.

    Abstract:

    Nevirapine is one of the first line agents of the anti-retroviral therapy (ART) used widely in the management of human immunodeficiency virus (HIV) infection and also in acquired immunodeficiency syndrome (AIDS). Anemia is often reported in the individuals taking ART. We report a case of Nevirapine induced autoimmune haemolytic anemia (AIHA). This case report creates awareness on the hematologic abnormality caused by the drug requiring immediate medical attention.

    Key words: Drug induced blood disorder, Drug rash, Altered hematology and Quality of life.

    Download Article >>

     




     

    Cite this article as

    Devulapalli M, G.V NK. A Case Report on Nevirapine Induced Autoimmune Hemolytic Anemia. Journal of Pharmacy Practice and Community Medicine. 2016;2(3):94-5. Abstract